Financing, Equity Capital Markets

Cara Therapeutics Inc.

07/18
|
$98.3 Million
Piper Sandler served as bookrunner for Cara Therapeutics, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma